Immunogenicity and safety of quadrivalent recombinant influenza vaccine in Korean adults: Phase III, randomized study. Choi WS, Lee J, Ottaviano C, Samson S, et al. Vaccine 2025;62:127521.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Choi WS, Lee J, Ottaviano C, Samson S, et al. Immunogenicity and safety of quadrivalent recombinant influenza vaccine in Korean adults: Phase III, randomized study. Vaccine 2025;62:127521.
PMID: 40752250